Re: “An entrepreneur’s health care enrollment advice to all Tennessee employers | Opinion,” by Dr. Hana Ali, Oct. 29. If you read Dr. Ali’s guest column, you might feel alarmed about some changes BlueCross has made to how provider-administered specialty …
BCBST News Center: Responding to Continued Misleading Claims by the Coalition of State Rheumatology Organizations
In a pair of recent press releases, the Coalition of State Rheumatology Organizations (CSRO) continued to incite fear in patients as it attempts to fight our specialty pharmacy changes. Our program, which went into effect Jan. 1, 2020, requires providers …
BCBST News Center: Moving forward with flexibility: Q&A on our specialty pharmacy changes
Key Takeaways Starting Jan. 1, BlueCross changed the way providers should obtain specialty drugs they administer to patients, like infusions. We didn’t change what drugs we cover or ask members to change where they get care. Tennessee employers have asked …
BCBST News Center: BlueCross Sets the Record Straight about our Specialty Drug Program
A response to the American College of Rheumatology and other provider organizations Specialty drugs account for about 1% of prescriptions covered by BlueCross, but account for about 50% of our total drug costs. Tennessee employers have been asking us to …
BCBST News Center: Response to Misleading Claims by the Coalition of State Rheumatology Organizations about our Specialty Pharmacy Program
In a press release issued Jan. 29, 2020, CSRO appears to be intentionally spreading misinformation and fear, as evidenced by their claim that physicians will no longer be able to infuse patients in their office. Our program does not require …